Chutchawan Ungthammakhun
Bangkok, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Oral fosfomycin after carbapenems as de-escalating therapy in complicated urinary tract infections: A randomized controlled trial.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: March 31, 2026
Clinical Relevance of Antimicrobial Susceptibility Testing Methods in Carbapenem-Resistant Acinetobacter baumannii Pneumonia: A Secondary Analysis of a Randomized Controlled Trial.
Journal: Antibiotics (Basel, Switzerland)
Published: December 19, 2025
Authors' reply: "Effect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: a randomized controlled trial".
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: January 16, 2025
The Mortality of Colistin Monotherapy vs. Colistin-Sulbactam for Carbapenem-Resistant Acinetobacter baumannii Pneumonia: A Propensity Score Analysis.
Journal: Infection & chemotherapy
Published: November 10, 2024
The Effects of the Early and Late Phases of Septic Shock on the Population Pharmacokinetics of Vancomycin.
Journal: Journal of clinical pharmacology
Published: October 31, 2024
Effect of colistin combined with sulbactam: 9 g versus 12 g per day on mortality in the treatment of carbapenems resistant Acinetobacter baumannii pneumonia: A randomized controlled trial.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: August 13, 2024
A Randomized Controlled Trial of Colistin Combined with Sulbactam: 9 g per Day versus 12 g per Day in the Treatment of Extensively Drug-Resistant Acinetobacter baumannii Pneumonia: An Interim Analysis.
Journal: Antibiotics (Basel, Switzerland)
Published: July 25, 2022
Clinical Outcomes Of Colistin In Combination With Either 6-G Sulbactam Or Carbapenems For The Treatment Of Extensively Drug-Resistant Acinetobacter Baumannii Pneumonia With High MIC To Sulbactam, A Prospective Cohort Study.
Journal: Infection and drug resistance
Published: July 31, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026